ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Buys AP214 Hormone From Action Pharma For $110 Million

DOW JONES NEWSWIRES Abbott Laboratories (ABT) took another step to enhance its renal-care pipeline by agreeing to acquire AP214, a hormone analogue that may prevent acute kidney injury during cardiac surgery, from Action Pharma A/S for $110 million in cash. The health-care company has been on a buying spree in recent years in order to reduce its dependence on the anti-inflammatory Humira as the drug's U.S. patent expires in late 2016. Abbott also is in the midst of separating into two publicly traded companies: a medical-products business and a pharmaceutical company to be named AbbVie. Abbott will acquire all global rights to develop and market AP214, and will be responsible for funding all future development and commercialization activities. No later milestone payments or royalties will be paid to the Danish biotech company Action Pharma. Abbott currently has two investigational treatments in development for chronic kidney disease: Bardoxolone, which is in Phase 3 development with Reata Pharmaceuticals, and Atrasentan, a compound discovered by Abbott being evaluated in a Phase 2b study. -By Melodie Warner, Dow Jones Newswires; 212-416-2283;

Stock News for Abbott Labs (ABT)
10/12/201516:00:00Abbott Laboratories Dissolving Stent Shows Mixed Results
10/12/201515:57:00Abbott Laboratories Dissolving Stent Shows Mixed Results in Study
10/12/201514:25:00Abbott Announces Positive Clinical Results of Absorb™, the N...
10/12/201510:07:14Markets Soar, Markets Orbit And Markets Crash
10/09/201514:44:42Boston Arrives Late To The Mitral Valve Party
10/02/201517:11:28Statement of Changes in Beneficial Ownership (4)
10/02/201517:10:36Statement of Changes in Beneficial Ownership (4)
10/02/201517:09:18Statement of Changes in Beneficial Ownership (4)
10/02/201517:08:55Statement of Changes in Beneficial Ownership (4)
10/01/201513:00:00Abbott Celebrates Living Fully Through the Power of Health as...
09/30/201509:00:00Abbott Hosts Conference Call for Third-Quarter Earnings
09/29/201517:37:24Statement of Changes in Beneficial Ownership (4)
09/23/201509:15:00Sponsorships and Partnerships for Scheduled Events - Report...
09/22/201510:00:00What Does It Mean to Live Fully?
09/22/201508:00:00Abbott Marks 15 Years of Helping Career-Minded Moms Reach Their...
09/18/201508:30:00Medical Appliances and Equipment Stocks Technical Report -- Boston...
09/17/201509:00:00Abbott Declares 367th Consecutive Quarterly Dividend
09/16/201508:00:00Nouvelle technologie pouvant offrir une vision utile sur une...
09/16/201508:00:00New Technology Can Offer People with Cataracts a Full Range of...
09/10/201512:47:00Abbott Named Industry Leader for Responsible and Sustainable...

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations